FDA issued a Warning Letter to Lupin Limited on 5/7/2009 as a result of this inspection.
FDA investigators audited the Lupin - Mandideep, India facility and issued inspectional observations (via FDA 483) on 12 Nov 2008.
Product details
- Category: Human Drugs
- Inspection end: 12 Nov 2008
- Location: Mandideep, India
- FEI: 3002807511
